Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Fdopa

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00674440Phase 2Completed

Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism

Showing all 1 trials

Research Network

Common Treatments

  • Fdopa1
  • Pet Scan1

Active Sponsors

  • Children's Hospital of Philadelphia1
  • University of Pennsylvania1

Top Investigators

Related Conditions

  • Phhi1
  • Persistent Hyperinsulinemic Hypoglycemia Of Infancy1
  • Hyperinsulinism1
  • Congenital Hyperinsulinism1

Activity Timeline